Items where authors include "Tooze, R"

Export as [feed] Atom [feed] RSS
Number of items: 19.

Article

Davies, AJ, Barrans, S, Stanton, L et al. (20 more authors) (2023) Differential Efficacy From the Addition of Bortezomib to R-CHOP in Diffuse Large B-Cell Lymphoma According to the Molecular Subgroup in the REMoDL-B Study With a 5-Year Follow-Up. Journal of Clinical Oncology, 41 (15). pp. 2718-2723. ISSN 0732-183X

Robinson, E, Care, M orcid.org/0000-0001-6584-5889, Walker, K orcid.org/0000-0002-6694-2979 et al. (3 more authors) (2022) A System for In Vitro Generation of Mature Murine Plasma Cells Uncovers Differential Blimp-1/Prdm1 Promoter Usage. Journal of Immunology, 208 (2). pp. 514-525. ISSN 0022-1767

Stockdale, C, Rice, L, Carter, C et al. (7 more authors) (2021) Novel Case of Tripeptidyl Peptidase 2 Deficiency Associated with Mild Clinical Phenotype. Journal of Clinical Immunology, 41 (5). pp. 1123-1127. ISSN 0271-9142

Ahmed, S orcid.org/0000-0003-4912-746X, Glover, P, Taylor, J et al. (8 more authors) (2021) Comparative analysis of gene expression platforms for cell‐of‐origin classification of diffuse large B‐cell lymphoma shows high concordance. British Journal of Haematology, 192 (3). bjh.17246. pp. 599-604. ISSN 0007-1048

Lara-Reyna, S, Poulter, JA orcid.org/0000-0003-2048-5693, Vasconcelos, EJR orcid.org/0000-0001-5130-6622 et al. (5 more authors) (2021) Identification of Critical Transcriptomic Signaling Pathways in Patients with H Syndrome and Rosai-Dorfman Disease. Journal of Clinical Immunology, 41 (2). pp. 441-457. ISSN 0271-9142

El-Sherbiny, YM orcid.org/0000-0003-4791-3475, Md Yusof, MY orcid.org/0000-0003-3131-9121, Psarras, A et al. (11 more authors) (2020) B Cell Tetherin: A Flow Cytometric Cell‐Specific Assay for Response to Type I Interferon Predicts Clinical Features and Flares in Systemic Lupus Erythematosus. Arthritis & Rheumatology, 72 (5). pp. 769-779. ISSN 2326-5191

Cucco, F, Barrans, S, Sha, C et al. (21 more authors) (2020) Distinct genetic changes reveal evolutionary history and heterogeneous molecular grade of DLBCL with MYC/BCL2 double-hit. Leukemia, 34. pp. 1329-1341. ISSN 0887-6924

Lupino, L, Perry, T, Margielewska, S et al. (18 more authors) (2019) Sphingosine-1-phosphate signalling drives an angiogenic transcriptional programme in diffuse large B cell lymphoma. Leukemia, 33. pp. 2884-2897. ISSN 0887-6924

Painter, D, Barrans, S, Lacy, S et al. (8 more authors) (2019) Cell‐of‐origin in diffuse large B‐cell lymphoma: findings from the UK's population‐based Haematological Malignancy Research Network. British Journal of Haematology, 185 (4). pp. 781-784. ISSN 0007-1048

Davies, A, Cummin, TE, Barrans, S et al. (21 more authors) (2019) Gene-expression profiling of bortezomib added to standard chemoimmunotherapy for diffuse large B-cell lymphoma (REMoDL-B): an open-label, randomised, phase 3 trial. The Lancet Oncology, 20 (5). pp. 649-662. ISSN 1470-2045

Sha, C, Barrans, S, Cucco, F et al. (20 more authors) (2019) Molecular high-grade B cell lymphoma: defining a poor risk group requiring different approaches to therapy. Journal of Clinical Oncology, 37 (3). pp. 202-213. ISSN 0732-183X

El-Sherbiny, YM orcid.org/0000-0003-4791-3475, Psarras, A, Yusof, MYM et al. (8 more authors) (2018) Publisher Correction: A novel two-score system for interferon status segregates autoimmune diseases and correlates with clinical features. Scientific Reports, 8. ARTN 14846. ISSN 2045-2322

Bigley, V, Maisuria, S, Cytlak, U et al. (20 more authors) (2018) Biallelic interferon regulatory factor 8 mutation: A complex immunodeficiency syndrome with dendritic cell deficiency, monocytopenia, and immune dysregulation. Journal of Allergy and Clinical Immunology, 141 (6). pp. 2234-2248. ISSN 0091-6749

Robinson, E, Care, M orcid.org/0000-0001-6584-5889, Tooze, R orcid.org/0000-0003-2915-7119 et al. (1 more author) (2018) Salt-Inducible kinases are critical regulators of terminal B-cell differentiation. Journal of Immunology, 200 (1). Supplement 171.3. ISSN 0022-1767

El-Sherbiny, YM orcid.org/0000-0003-4791-3475, Psarras, A, Md Yusof, M et al. (8 more authors) (2018) A novel two-score system for interferon status segregates autoimmune diseases and correlates with clinical features. Scientific Reports, 8. 5793. ISSN 2045-2322

Vrzalikova, K, Ibrahim, M, Vockerodt, M et al. (19 more authors) (2017) S1PR1 drives a feedforward signalling loop to regulate BATF3 and the transcriptional programme of Hodgkin lymphoma cells. Leukemia, 32. pp. 214-223. ISSN 0887-6924

Sha, C, Barrans, S, Care, MA et al. (4 more authors) (2015) Transferring genomics to the clinic: distinguishing Burkitt and diffuse large B cell lymphomas. Genome Medicine: medicine in the post-genomic era, 7. 64. ISSN 1756-994X

Proceedings Paper

Cutmore, NH, Taylor, S, Stockdale, C et al. (3 more authors) (2019) OCT2 as a Diagnostic Immunohistochemical Marker in Rosai-Dorfman Disease. In: Journal of Pathology. Leeds Pathology 2019. Joint meeting of the British Division of the International Academy of Pathology and the Pathological Society of Great Britain & Ireland, 02-04 Jul 2019, Leeds. Wiley , S42-S42.

Cullen, M, Richards, S, Bowen, D et al. (3 more authors) (2017) The Application of Machine Learning Algorithms to Immunophenotypic Data to Aid in the Diagnosis of MDS. In: Leukemia Research. The 14th International Symposium of Myelodysplastic Syndromes (MDS), 03-06 May 2017, Valencia, Spain. Elsevier Ltd. , S95-S95.

This list was generated on Sun Apr 21 20:53:16 2024 BST.